An innovative approach for the characterization of the isoforms of a monoclonal antibody product

New drugs in melanoma: It’s a whole new world

(2011) Alexander M.M. Eggermont et al.   EUROPEAN JOURNAL OF CANCER

Antibody-based therapeutics to watch in 2011

(2011) Janice M. Reichert   mAbs

Characterization of Antibody Charge Heterogeneity Resolved by Preparative Immobilized pH Gradients

(2010) Charlie D. Meert et al.   ANALYTICAL CHEMISTRY

Metrics for antibody therapeutics development

(2010) Janice M. Reichert   mAbs

Engineering host cell lines to reduce terminal sialylation of secreted antibodies

(2010) Michael F. Naso et al.   mAbs

Evidence for Trisulfide Bonds in a Recombinant Variant of a Human IgG2 Monoclonal Antibody

(2009) Pavlo Pristatsky et al.   ANALYTICAL CHEMISTRY

Recombinant Antibodies as Therapeutic Agents

(2008) Frederico Aires da Silva et al.   BIODRUGS

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells

(2008) M. Peipp et al.   BLOOD

Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods

(2008) J. Vlasak et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY